1. Home
  2. Labeler Index
  3. Redpharm Drug, Inc.
  4. 67296-1264
  5. NDC Package Code: 67296-1264-3 Terazosin

NDC Package 67296-1264-3 Terazosin

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
67296-1264-3
Package Description:
30 CAPSULE in 1 BOTTLE
Product Code:
67296-1264
Proprietary Name:
Terazosin
Usage Information:
Terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with terazosin capsules. The long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of BPH are yet to be determined.Terazosin capsules are also indicated for the treatment of hypertension. Terazosin capsules can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.
11-Digit NDC Billing Format:
67296126403
NDC to RxNorm Crosswalk:
  • RxCUI: 313215 - terazosin HCl 1 MG Oral Capsule
  • RxCUI: 313215 - terazosin 1 MG Oral Capsule
  • RxCUI: 313215 - terazosin (as terazosin HCl) 1 MG Oral Capsule
    • Labeler Name:
    Redpharm Drug, Inc.
    Sample Package:
    No
    Start Marketing Date:
    12-20-2004
    Listing Expiration Date:
    12-31-2023
    Exclude Flag:
    I
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 67296-1264-3?

    The NDC Packaged Code 67296-1264-3 is assigned to a package of 30 capsule in 1 bottle of Terazosin, labeled by Redpharm Drug, Inc.. The product's dosage form is and is administered via form.

    Is NDC 67296-1264 included in the NDC Directory?

    No, Terazosin with product code 67296-1264 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Redpharm Drug, Inc. on December 20, 2004 and its listing in the NDC Directory is set to expire on December 31, 2023 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 67296-1264-3?

    The 11-digit format is 67296126403. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-167296-1264-35-4-267296-1264-03